Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-200,000
Closed -$26M 102
2025
Q4
$26M Buy
+200,000
New +$28.6M 2.48% 10
2020
Q4
Sell
-35,000
Closed -$8.26M 89
2020
Q3
$8.26M Buy
+35,000
New +$7.85M 2.19% 14

Other funds holding MASI

Parkman Healthcare Partners's MASI Position: Q1 2026 in Review

Parkman Healthcare Partners sold out of Masimo (MASI) in Q1 2026, closing a stake of 200,000 shares — an estimated $26M sold.

Parkman Healthcare Partners first reported a position in MASI in Q3 2020 and held it in 2 quarters. The position peaked at $26M in Q4 2025. 445 funds tracked by Wall St. Rank hold MASI as of Q1 2026.

  • Parkman Healthcare Partners reported no remaining Masimo position as of Q1 2026 after selling out during the quarter.
  • Parkman Healthcare Partners sold 200,000 Masimo shares in Q1 2026, an estimated $26M.
  • Parkman Healthcare Partners first reported a position in Masimo in Q3 2020 and held it in 2 quarters.
  • Parkman Healthcare Partners's Masimo position peaked at $26M in Q4 2025.
  • 445 funds tracked by Wall St. Rank held Masimo as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.